by A recent study published in the journal “Addiction” has revealed intriguing findings regarding the potential connection between cannabis use and the risk of experiencing severe COVID-19 symptoms.
Addiction as Researchers from the University of California, San Diego, analyzed data from over 2,000 adult patients who tested positive for COVID-19 between March and December 2020. Among these participants, 14% reported using cannabis within 30 days prior to their COVID-19 diagnosis.
The study’s findings indicated that cannabis users were more likely to experience severe COVID-19 symptoms, such as shortness of breath, hospitalization, and ICU admission, compared to non-users. Specifically, cannabis users were 1.4 times more likely to be hospitalized and 2.1 times more likely to be admitted to the ICU.
The researchers also noted that the association between cannabis use and severe COVID-19 outcomes remained significant even after adjusting for various confounding factors, such as age, sex, race, and underlying health conditions.
However, it is important to note that this study does not establish a causal relationship between cannabis use and increased risk of severe COVID-19. Further research is needed to fully understand the underlying mechanisms and potential explanations for these findings.
In summary, the new study adds to the growing body of evidence suggesting that cannabis use may be linked to higher risk of experiencing severe COVID-19 symptoms. However, more research is needed to fully understand the nature of this association.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
